Probiotic Spore Inspired Oral Drug Delivery System With Multiple‐Barriers‐Crossing Ability Modulates Gut‐Brain Axis for Parkinson's Disease Therapy
Exploration · 2026-10 · 6 (5)
DOI: 10.1002/exp2.70221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration, online erschienen am 09.09.2026. Verfasst von Qianhua Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences State Key Laboratory of Antiviral Drugs Pingyuan Laboratory Zhengzhou University Zhengzhou China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
For Parkinson's disease (PD), the development of oral brain‐targeted drug delivery is challenging due to various physiological barriers. Besides the brain, the effect of the gut on the microbiome‐gut‐brain axis should not be ignored. Therefore, developing a gut‐brain dual‐targeted delivery system with multiple‐barriers‐crossing ability is meaningful. During the germination of probiotic spores, we find that spore coat proteins (SP) shed from their surface possess excellent characteristics (re‐assembling into nanoparticles, multiple‐barriers penetration ability, antioxidant property, etc.), offering potential for brain‐targeted drug delivery. Inspired by this, we propose a probiotic spore based oral drug delivery system to dual‐regulate the gut‐brain. After oral administration, the spore system crosses the harsh gastrointestinal chemical barrier. Spores germinate in the intestine into probiotics to modulate the gut‐brain axis. Meanwhile, the SP‐derived reassembled nanosystems cross multiple barriers (intestinal mucus barrier, enterocyte barrier, blood‐brain barrier) to reach brain and further reduce oxidative stress. Notably, neurodegeneration and behavioral deficits are alleviated in PD mice. Such gut‐brain dual‐regulation strategy emphasizes a comprehensive and promising technique for central nervous system disease treatment, which may be an alternative to traditional single‐targeted methods. Furthermore, the probiotic spore‐based oral biotherapeutics with multiple‐barriers‐crossing efficiency provide new insight into other brain diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences State Key Laboratory of Antiviral Drugs Pingyuan Laboratory Zhengzhou University Zhengzhou China.
- Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases Zhengzhou China.
- Hubei Provincial Clinical Research Center for Central Nervous System Repair and Functional Reconstruction Taihe Hospital Hubei University of Medicine Shiyan Hubei China.
- Department of Pharmacy Henan General Hospital Zhengzhou China.
- School of Electrical Mechanical and Biomedical Engineering Faculty of Engineering and Information Technology University of Technology Sydney Sydney New South Wales Australia.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Feng, Q., Mei, Y., Zhang, J., Sun, L., Si, B., Zhou, H., Xiao, H., Liu, R., Zhang, J., & Wang, L. (2026). Probiotic Spore Inspired Oral Drug Delivery System With Multiple‐Barriers‐Crossing Ability Modulates Gut‐Brain Axis for Parkinson's Disease Therapy. Exploration, 6(5). https://doi.org/10.1002/exp2.70221
Vancouver
Feng Q, Mei Y, Zhang J, Sun L, Si B, Zhou H, et al. Probiotic Spore Inspired Oral Drug Delivery System With Multiple‐Barriers‐Crossing Ability Modulates Gut‐Brain Axis for Parkinson's Disease Therapy. Exploration. 2026;6(5). doi:10.1002/exp2.70221
BibTeX
@article{Feng2026,
author = {Feng, Qianhua and Mei, Yuying and Zhang, Jia and Sun, Liying and Si, Bingqian and Zhou, Huimin and Xiao, Huifang and Liu, Runhan and Zhang, Jieyun and Wang, Lei},
title = {Probiotic Spore Inspired Oral Drug Delivery System With Multiple‐Barriers‐Crossing Ability Modulates Gut‐Brain Axis for Parkinson's Disease Therapy},
journal = {Exploration},
year = {2026},
volume = {6},
number = {5},
doi = {10.1002/exp2.70221}
}
EUVIMED